An image of a smartphone and a pen
Markets

Pfizer Added to JPMorgan’s “Analyst Focus” List (PFE)

Drugmaker Pfizer Inc. ( PFE ) on Wednesday caught an upgrade from analysts at JPMorgan.

The firm said it added PFE to its "Analyst Focus List" with a $25 price target, suggesting a massive 42% upside to the stock's Tuesday closing price of $17.60.

JPMorgan noted that PFE is a solid defensive stock to own in during a very uncertain market environment.

Pfizer shares fell 25 cents, or -1.4%, in premarket trading Wednesday.

The Bottom Line

We have been recommending shares of Pfizer ( PFE ) since Mar.17, when the stock was trading at $19.11. The company has a 4.55% dividend yield, based on last night's closing stock price of $17.60.

Pfizer Inc. ( PFE ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.6 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PFE

Other Topics

Stocks

Latest Markets Videos